As T2D is often associated with having a high body mass index, one would be forgiven for assuming that the needs of people who use GLP-1s for weight loss and those using it to treat diabetes would be very similar, but recent market research suggests a number of significant differences:5 The majority of people using GLP-1s for weight loss are in their 30s to 50s (often as part of a wider strategy to be proactive about their health), whereas those using GLP-1s for diabetes control are more likely to be over 60
Start your intake How Magnesium Affects Digestive Function During GLP-1 Therapy Magnesium plays a critical role in muscle contraction and nervous system signaling throughout the digestive tract
However, this effect might be independent of changes in visceral fat accumulation since previous studies have demonstrated that the hepatic glucose production is decreased in healthy individuals following acute administration of both native GLP-1 (44)
Oral vs injectable GLP-1 RAs: dosing and adherence Administration options for GLP-1 receptor agonists include daily oral tablets (semaglutide), daily injections (liraglutide, lixisenatide), and weekly injections (semaglutide, dulaglutide, exenatide-ER)